Here's Why We're Not Too Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Situation

Here's Why We're Not Too Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Situation

Investors are attracted to unprofitable companies like Salesforce.com, but they must be cautious of those that burn through cash and collapse. Trevi Therapeutics has a cash runway of 2.

Read More

Did you find this insightful?